genedrive plc (LON:GDR – Get Free Report) crossed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 1.19 and traded as low as GBX 1.15. genedrive shares last traded at GBX 1.22, with a volume of 5,948,941 shares traded.
genedrive Price Performance
The firm has a market cap of £18.95 million, a P/E ratio of -1.49 and a beta of 0.99. The company has a debt-to-equity ratio of -120.48, a current ratio of 0.99 and a quick ratio of 5.52. The stock’s 50-day simple moving average is GBX 1.19 and its two-hundred day simple moving average is GBX 1.10.
genedrive Company Profile
genedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.
Further Reading
- Five stocks we like better than genedrive
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
- AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
- NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
- Apple’s Next iPhone Could Test How Much Pricing Power Is Left
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.
